Mohammad Mohiminul Islam
Overview
Explore the profile of Mohammad Mohiminul Islam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
64
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rajaratnam V, Islam M, Kub E, Rajaratnam S, Kim K, Rahman M, et al.
Biomed Chromatogr
. 2023 Sep;
38(1):e5754.
PMID: 37750452
Despite aggressive treatment approaches, the overall survival of glioblastoma (GBM) patients remained poor with a strong need for more effective chemotherapeutic agents. A previous study has shown that ARN14988 is...
2.
Islam M, Kub E, Rajaratnam V, Mirza S
J Chromatogr B Analyt Technol Biomed Life Sci
. 2022 Nov;
1212:123516.
PMID: 36332509
Carmofur is an acid ceramidase inhibitor with superior efficacy in suppressing and killing fatally aggressive glioblastoma cell lines compared to the FDA-approved drug temozolomide. In addition to brain tumors, carmofur...
3.
Islam M, Mirza S
Drug Dev Res
. 2022 Aug;
83(7):1505-1518.
PMID: 36031762
Carmofur, 1-hexylcarbamoyl-5-fluorouracil (HCFU) is an antineoplastic drug, which has been in clinics in Japan since 1981 for the treatment of colorectal cancer. Subsequently, it was also introduced in China, Korea,...
4.
Rajaratnam V, Islam M, Yang M, Slaby R, Ramirez H, Mirza S
Cancers (Basel)
. 2020 Apr;
12(4).
PMID: 32290213
Glioblastoma is one of the most common and detrimental forms of solid brain tumor, with over 10,000 new cases reported every year in the United States. Despite aggressive multimodal treatment...